Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2007
12/20/2007US20070293446 Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292718 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
12/20/2007DE102006032168A1 Anthranilsäurediamid-Derivate mit heteroaromatischen Substituenten Anthranilsäurediamid derivatives with heteroaromatic substituents
12/19/2007EP1867646A1 Cytokine inhibitors
12/19/2007EP1867645A1 Variolin derivatives and their use as antitumor agents
12/19/2007EP1867644A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
12/19/2007EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
12/19/2007EP1867636A1 Pyridylmethylsulfone derivative
12/19/2007EP1866304A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/19/2007EP1866302A1 Pyrazole derivatives
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1866287A2 Substituted pyrazolyl oxyphenyl derivatives used as herbicides
12/19/2007EP1866286A1 Pyridine derivatives useful as inhibitors of pkc-theta
12/19/2007EP1865958A2 Pharmacokinetically improved compounds
12/19/2007EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
12/19/2007EP1865774A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/19/2007EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors
12/19/2007EP1732562B1 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1601358B1 2,5-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
12/19/2007EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity
12/19/2007EP1503757B1 Tyrosine kinase inhibitors
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1470122B1 Rho-kinase inhibitors
12/19/2007EP1465875B1 Novel alkansulfonamides as endothelin antagonists
12/19/2007EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1165068B1 C10 heterosubstituted acetate taxanes as antitumor agents
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090898A 5-HT7 receptor antagonists
12/19/2007CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
12/19/2007CN101088998A Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/19/2007CN100355749C Crystals of benzimidazole derivatives and their production
12/19/2007CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor
12/19/2007CN100355734C Preparation of quinoline-substituted carbonate and carbamate derivatives
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355729C Pleuromutilin
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/19/2007CN100355423C Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309788 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/18/2007US7309712 1H-pyrazoles useful in therapy
12/18/2007US7309710 Crystals
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension.
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/18/2007US7309615 High quantum yield acridinium compounds and their uses in improving assay sensitivity
12/18/2007CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/13/2007WO2007142585A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007WO2007142584A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007WO2007142583A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia.
12/13/2007WO2007142580A1 Novel method for preparation of ammonium salts of esomeprazole
12/13/2007WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007WO2007142308A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator
12/13/2007WO2007142217A1 1-phenylpyridone derivative
12/13/2007WO2007141200A1 Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in mch-1 mediated diseases
12/13/2007WO2007141039A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/13/2007WO2007140957A1 Sulfimides as protein kinase inhibitors
12/13/2007WO2007140608A1 A novel process for the preparation of esomeprazole and salts thereof
12/13/2007WO2007127763A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/13/2007WO2007119001A3 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
12/13/2007WO2007117982A3 Organic compounds
12/13/2007WO2007111904A3 C-met protein kinase inhibitors for the treatment of proliferative disorders
12/13/2007WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/13/2007WO2007109211A3 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
12/13/2007WO2007089743A3 Potassium channel inhibitors
12/13/2007WO2007078813A3 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION
12/13/2007WO2007070506A3 Diaza heterocyclic sulfonamide derivatives and their uses
12/13/2007WO2007044796A3 Pyridazinone compounds as calcilytics
12/13/2007US20070287839 Novel process for the preparation of esomeprazole and salts thereof
12/13/2007US20070287737 Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
12/13/2007US20070287736 Diphenyl Substituted Alkanes as Flap Inhibitors
12/13/2007US20070287735 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
12/13/2007US20070287721 Pyrazolopyridinyl pyridine
12/13/2007US20070287715 e.g.5-(4-tert-Butylphenyl-1-(4-(2-carboxypropan-2-yloxy)phenyl)indole-2-carboxylic acid ; inhibition of the activity of microsomal prostaglandin E synthase-1, 5-lipoxygenase-activating protein (FLAP); respiratory system disorders
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287712 antiviral agents for the treatment of HIV and AIDS; indole and azaindole piperazine enamine derivatives; 2-((4-(2-(4-fluoro-7-(1H-1,2,3-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetyl)piperazin-1-yl)(phenyl)methylene)malononitrile
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007US20070287709 Novel arylamino N-heteraryls as MEK inhibitors
12/13/2007US20070287699 Antiviral agents
12/13/2007US20070287698 Tetrahydrobenzo(D)Azepin-2-One Derivatives and the Use Thereof for Treating Cardiovascular Diseases
12/13/2007US20070287696 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
12/13/2007DE102006027156A1 New sulfimide compounds are protein kinase inhibitors useful to treat e.g. cancer, Hodgkin's lymphoma, Kaposi's sarcoma, cardiovascular disease, Crohn's disease, endometriosis and hemangioma
12/13/2007CA2654427A1 A novel process for the preparation of esomeprazole and salts thereof
12/13/2007CA2654318A1 Sulphimides as protein kinase inhibitors
12/13/2007CA2654147A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007CA2654138A1 Novel compounds
12/13/2007CA2653655A1 Organic compounds
12/13/2007CA2653526A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/13/2007CA2653429A1 Novel method for preparation of ammonium salts of esomeprazole
12/13/2007CA2653424A1 Novel indazole derivative having spiro ring structure in side chain
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864980A1 Antifungal agent containing pyridine derivative
1 ... 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 ... 1080